ForeverGreen Receives Clinical Study Results On Marine Phytoplankton
May 15th 2008Drug InformationComplementary Medicine
ForeverGreen Corp. (OTCBB:FVRG), a manufacturer and distributor of all natural whole foods, announced the company has received the preliminary findings of a recently completed medical study of the benefits of marine phytoplankton to humans. Scientific evidence has proven one of the key ingredients in ForeverGreen’s FrequenSea, Alpha 3 concentrated marine phytoplankton (Alpha 3CMP), does in fact benefit humans who consume the product.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
